| Advances in bladder cancer biology and therapy L Tran, JF Xiao, N Agarwal, JE Duex, D Theodorescu Nature Reviews Cancer 21 (2), 104-121, 2021 | 534 | 2021 |
| Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression Y Jiang, YY Jiang, JJ Xie, A Mayakonda, M Hazawa, L Chen, JF Xiao, ... Nature communications 9 (1), 3619, 2018 | 204 | 2018 |
| Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma YY Jiang, DC Lin, A Mayakonda, M Hazawa, LW Ding, WW Chien, L Xu, ... Gut 66 (8), 1358-1368, 2017 | 204 | 2017 |
| SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway QY Sun, LW Ding, JF Xiao, W Chien, SL Lim, N Hattori, L Goodglick, ... The Journal of pathology 235 (4), 559-570, 2015 | 109 | 2015 |
| Mutational landscape of pediatric acute lymphoblastic leukemia LW Ding, QY Sun, KT Tan, W Chien, AM Thippeswamy, A Eng Juh Yeoh, ... Cancer Research 77 (2), 390-400, 2017 | 99 | 2017 |
| Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells W Chien, LW Ding, QY Sun, LA Torres-Fernandez, SZ Tan, J Xiao, SL Lim, ... Oncotarget 5 (13), 4881, 2014 | 94 | 2014 |
| Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD) QY Sun, LW Ding, KT Tan, W Chien, A Mayakonda, DC Lin, XY Loh, ... Leukemia 31 (1), 1-10, 2017 | 76 | 2017 |
| RNA-Binding Protein ZFP36L1 Suppresses Hypoxia and Cell-Cycle Signaling XY Loh, QY Sun, LW Ding, A Mayakonda, N Venkatachalam, MS Yeo, ... Cancer research 80 (2), 219-233, 2020 | 54 | 2020 |
| Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture models K Mimura, LF Kua, JF Xiao, BR Asuncion, Y Nakayama, N Syn, Z Fazreen, ... Gastric Cancer 24, 611-623, 2021 | 51 | 2021 |
| SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cells QY Sun, LW Ding, K Johnson, S Zhou, JW Tyner, H Yang, NB Doan, ... Oncogene 38 (34), 6196-6210, 2019 | 49 | 2019 |
| Targetable pathways in advanced bladder cancer: FGFR signaling JF Xiao, AW Caliri, JE Duex, D Theodorescu Cancers 13 (19), 4891, 2021 | 40 | 2021 |
| The c‐MYC–BMI1 axis is essential for SETDB1‐mediated breast tumourigenesis JF Xiao, QY Sun, LW Ding, W Chien, XY Liu, A Mayakonda, YY Jiang, ... The Journal of Pathology 246 (1), 89-102, 2018 | 37 | 2018 |
| LNK suppresses interferon signaling in melanoma LW Ding, QY Sun, JJ Edwards, LT Fernández, XB Ran, SQ Zhou, ... Nature communications 10 (1), 2230, 2019 | 27 | 2019 |
| LNK (SH2B3): paradoxical effects in ovarian cancer LW Ding, QY Sun, DC Lin, W Chien, N Hattori, XM Dong, S Gery, M Garg, ... Oncogene 34 (11), 1463-1474, 2015 | 23 | 2015 |
| Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas MT Broz, EY Ko, K Ishaya, J Xiao, M De Simone, XP Hoi, R Piras, B Gala, ... Nature Communications 15 (1), 2498, 2024 | 22 | 2024 |
| Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD W Chien, QY Sun, LW Ding, A Mayakonda, S Takao, L Liu, SL Lim, ... Leukemia 31 (3), 762-766, 2017 | 15 | 2017 |
| Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines KT Tan, LW Ding, QY Sun, ZT Lao, W Chien, X Ren, JF Xiao, XY Loh, ... BMC cancer 18, 1-13, 2018 | 14 | 2018 |
| Targeting RNA exonuclease XRN1 potentiates efficacy of cancer immunotherapy XB Ran, LW Ding, QY Sun, H Yang, JW Said, L Zhentang, V Madan, ... Cancer Research 83 (6), 922-938, 2023 | 13 | 2023 |
| KDM6A depletion in breast epithelial cells leads to reduced sensitivity to anticancer agents and increased TGFβ activity JF Xiao, LF Kua, LW Ding, QY Sun, KN Myint, XR Chia, N Venkatachalam, ... Molecular Cancer Research 20 (4), 637-649, 2022 | 6 | 2022 |
| Clonality and clonal evolution analysis of paediatric ALL based on B‐cell receptor/T‐cell receptor rearrangement. LW Ding, KT Tan, QY Sun, ZT Lao, H Yang, N Jiang, W Chien, JF Xiao, ... British Journal of Haematology 184 (5), 2019 | 4 | 2019 |
